Acadia Healthcare Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Acadia Healthcare Company generated cash of $462,340,000, which is more than the previous year. Cash used in financing activities reached the amount of -$62,697,000 last year. Net change in cash is therefore $2,424,000.
Cash Flow
| 2014 | 115.28M | -860.77M | 837.97M |
|---|---|---|---|
| 2015 | 240.40M | -884.47M | 563.60M |
| 2016 | 361.47M | -660.36M | 358.84M |
| 2017 | 399.57M | -336.52M | -60.07M |
| 2018 | 414.08M | -360.96M | -67.33M |
| 2019 | 332.90M | -201.14M | -61.62M |
| 2020 | 658.80M | -281.83M | -51.49M |
| 2021 | 374.47M | 1.01B | -1.64B |
| 2022 | 380.56M | -305.83M | -110.90M |
| 2023 | 462.34M | -397.21M | -62.69M |
ACHC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 97.64M | 133.81M | 378.69M | 124.19M | 50.51M | 67.29M | 57.06M | 11.21M | 94.04M | 4.56M |
Operating activities | ||||||||||
Net income | -21.66M | 280.03M | 195.56M | -669.19M | 110.12M | -175.48M | 199.58M | 4.17M | 118.46M | 83.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 132.34M | 117.76M | 106.71M | 95.25M | 164.04M | 158.83M | 143.01M | 135.10M | 63.55M | 32.66M |
Stock-based compensation expense | 32.28M | 29.63M | 37.53M | 22.50M | 17.30M | 0 | 23.46M | 28.34M | 20.47M | 10.05M |
| Deferred income tax benefit | 32.28M | 29.63M | 37.53M | 22.50M | 17.30M | 0 | 23.46M | 28.34M | 20.47M | 10.05M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -39.01M | -41.97M | 2.44M | 15.34M | -19.06M | -16.82M | -28.57M | -15.71M | -24.95M | -15.11M |
Inventories | 0 | 0 | -13.98M | 19.30M | 6.47M | 29.61M | 11.82M | -29.22M | -1.05M | 9.96M |
Accounts payable | 17.40M | 5.17M | 6.16M | 77.99M | -21.35M | 26.05M | -10.11M | 22.69M | 6.86M | 2.79M |
Cash generated by operating activities | 462.34M | 380.56M | 374.47M | 658.80M | 332.90M | 414.08M | 399.57M | 361.47M | 240.40M | 115.28M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -84.79M | -8.34M | -7.61M | -18.38M | -41.05M | -40.75M | -26.62M | -23.17M |
Investments In Property Plant And Equipment | -424.13M | -296.14M | -244.81M | -216.61M | -284.68M | -341.46M | -274.17M | -307.47M | -276.04M | -113.24M |
Acquisitions Net | -349K | -9.50M | 1.37B | 92K | -45.67M | -18.19M | -18.19M | -310.18M | -574.77M | -738.70M |
Cash generated by investing activities | -397.21M | -305.83M | 1.01B | -281.83M | -201.14M | -360.96M | -336.52M | -660.36M | -884.47M | -860.77M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 184K | 0 | 0 | 685.09M | 685.09M | 331.30M | 374.43M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -52.53M | -17.79M | -5.73M | -1.84M | -1.64M | -3.40M | -3.45M | -8.84M | 0 | -4.09M |
Repayments of term debt | -16.25M | -113.59M | -2.56B | -1.05B | -52.98M | -61.65M | -57.30M | -1.93B | 274.06M | -291.69M |
Cash used in financing activities | -62.69M | -110.90M | -1.64B | -51.49M | -61.62M | -67.33M | -60.07M | 358.84M | 563.60M | 837.97M |
Net Change In Cash | 2.42M | -36.16M | -244.88M | 254.50M | 73.68M | -16.78M | 10.22M | 45.84M | -82.82M | 89.47M |
Cash at end of period | 100.07M | 97.64M | 133.81M | 378.69M | 124.19M | 50.51M | 67.29M | 57.06M | 11.21M | 94.04M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |